Stem Cell Regulation in India: Separating Legitimate Therapy Development from Regulatory Risk
Posted by: Saurangi Shah July 10, 2026
Introduction Stem cell therapy represents one Read More
Stem Cells
Revised Regulatory Guidelines For Sampling Of Drugs, Cosmetics & Medical Devices By Drugs Inspectors Of Central & State Drug Authorities
Posted by: Hitesh Gupta May 29, 2026
Read MoreDisposal/Rejection of Long Pending Applications on SUGAM Portal Awaiting Query Response
Posted by: Hitesh Gupta May 6, 2026
Read MoreGuidance document on dossier based licensing of Drugs for uniform product licensing in the country
Posted by: Hitesh Gupta April 1, 2026
Read More2026.01.22 G.S.R. 52(E)_Draft Notification for Revision of testing fees under Schedule B and B1
Posted by: Prabhas Chakraborty February 12, 2026
Read More2026.01.20 G.S.R. 45(E)_ Draft Notification for exemption of Animal Toxicity Studies w.r.t. certain conditions
Posted by: Prabhas Chakraborty February 10, 2026
Read MoreDisposal/Rejection of Long-Pending Applications on Sugam Portal Awaiting Query Response
Posted by: Hitesh Gupta February 2, 2026
Read More